Here is the CBS This Morning Segment about HSCT for RRMS, with Dr. Burt commenting on the treatments and results. There is a short but nice cost benefit ratio discussion about the cost of the treatment relative to MS drug costs.
It’s been a long time coming but it has finally happened!
The Journal of the American Medical Association (JAMA) has published Dr. Burt’s results from his Phase 3 Clinical Trial for HSCT ( Hematopoietic Stem Cell Transplant) treating RRMS (Relapse Remitting Multiple Sclerosis)!